Potent anti‐myeloma activity of the TOPK inhibitor OTS514 in pre‐clinical models

por Stefka, Andrew T., Johnson, David, Rosebeck, Shaun, Park, Jae‐Hyun, Nakamura, Yusuke, Jakubowiak, Andrzej J.
Publicado 2019

Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous ste...

por Derman, Benjamin A., Stefka, Andrew T., Jiang, Ken, McIver, Amanda, Kubicki, Tadeusz, Jasielec, Jagoda K., Jakubowiak, Andrzej J.
Publicado 2021

Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma

por Derman, Benjamin A., Zonder, Jeffrey, Reece, Donna, Cole, Craig, Berdeja, Jesus, Stefka, Andrew T., Major, Ajay, Kin, Andrew, Griffith, Kent, Jasielec, Jagoda, Jakubowiak, Andrzej J.
Publicado 2023

Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants

por Berni Canani, Roberto, Sangwan, Naseer, Stefka, Andrew T, Nocerino, Rita, Paparo, Lorella, Aitoro, Rosita, Calignano, Antonio, Khan, Aly A, Gilbert, Jack A, Nagler, Cathryn R
Publicado 2016